488 related articles for article (PubMed ID: 30099051)
1. Profiling of orthosteric and allosteric group-III metabotropic glutamate receptor ligands on various G protein-coupled receptors with Tag-lite
Belhocine A; Veglianese P; Hounsou C; Dupuis E; Acher F; Durroux T; Goudet C; Pin JP
Neuropharmacology; 2018 Sep; 140():233-245. PubMed ID: 30099051
[TBL] [Abstract][Full Text] [Related]
2. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
[TBL] [Abstract][Full Text] [Related]
3. Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α.
Jiang JY; Nagaraju M; Meyer RC; Zhang L; Hamelberg D; Hall RA; Brown EM; Conn PJ; Yang JJ
J Biol Chem; 2014 Jan; 289(3):1649-61. PubMed ID: 24280223
[TBL] [Abstract][Full Text] [Related]
4. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives.
Gasparini F; Kuhn R; Pin JP
Curr Opin Pharmacol; 2002 Feb; 2(1):43-9. PubMed ID: 11786307
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
Litim N; Morissette M; Di Paolo T
Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
Urwyler S
Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
[TBL] [Abstract][Full Text] [Related]
7. Development of allosteric modulators of GPCRs for treatment of CNS disorders.
Nickols HH; Conn PJ
Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101
[TBL] [Abstract][Full Text] [Related]
8. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of mGlu3 ligands using a high throughput FLIPR assay for detection of agonists, antagonists, and allosteric modulators.
Pratt SD; Mezler M; Geneste H; Bakker MH; Hajduk PJ; Gopalakrishnan SM
Comb Chem High Throughput Screen; 2011 Aug; 14(7):631-41. PubMed ID: 21534916
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of metabotropic glutamate receptors.
Sheffler DJ; Gregory KJ; Rook JM; Conn PJ
Adv Pharmacol; 2011; 62():37-77. PubMed ID: 21907906
[TBL] [Abstract][Full Text] [Related]
12. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
[TBL] [Abstract][Full Text] [Related]
13. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.
Goudet C; Vilar B; Courtiol T; Deltheil T; Bessiron T; Brabet I; Oueslati N; Rigault D; Bertrand HO; McLean H; Daniel H; Amalric M; Acher F; Pin JP
FASEB J; 2012 Apr; 26(4):1682-93. PubMed ID: 22223752
[TBL] [Abstract][Full Text] [Related]
14. A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors.
Niswender CM; Johnson KA; Luo Q; Ayala JE; Kim C; Conn PJ; Weaver CD
Mol Pharmacol; 2008 Apr; 73(4):1213-24. PubMed ID: 18171729
[TBL] [Abstract][Full Text] [Related]
15. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
[TBL] [Abstract][Full Text] [Related]
16. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
17. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
Orgován Z; Ferenczy GG; Keserű GM
Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248
[TBL] [Abstract][Full Text] [Related]
18. Identification of monellin as the first naturally derived proteinaceous allosteric agonist of metabotropic glutamate receptor 5.
Chen ANY; Hellyer SD; Trinh PNH; Leach K; Gregory KJ
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():104-115. PubMed ID: 30983151
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
Müller CE; Schiedel AC; Baqi Y
Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
[TBL] [Abstract][Full Text] [Related]
20. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.
Bennett KA; Christopher JA; Tehan BG
Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
